NORTHWEST BIOTHERAPEUTICS INC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $211.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-21
- NORTHWEST BIOTHERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$7.00K.
- NORTHWEST BIOTHERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $218.00K.
- NORTHWEST BIOTHERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$719.00K.
- NORTHWEST BIOTHERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $83.00K.
- NORTHWEST BIOTHERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$4.94M.
- NORTHWEST BIOTHERAPEUTICS INC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$6.75M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | $211.00K 10-Q · filed 2017-08-21 | -$508.00K derived: sum of 3 quarters · filed 2017-08-21 | -$425.00K derived: sum of 4 quarters · filed 2017-08-21 | |
| 2017-03-31 | $218.00K 10-Q · filed 2017-05-15 | -$501.00K derived: sum of 2 quarters · filed 2017-05-15 | -$418.00K derived: sum of 3 quarters · filed 2017-05-15 | -$2.04M derived: sum of 4 quarters · filed 2017-08-21 | |
| 2016-12-31 | -$719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | -$636.00K derived: sum of 2 quarters · filed 2017-04-17 | -$2.26M derived: sum of 3 quarters · filed 2017-08-21 | -$4.94M 10-K · filed 2017-04-17 | |
| 2016-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.54M derived: sum of 2 quarters · filed 2017-08-21 | -$4.22M 10-Q · filed 2016-11-10 | -$6.96M derived: sum of 4 quarters · filed 2017-08-21 | |
| 2016-06-30 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | -$4.30M 10-Q · filed 2017-08-21 | -$4.03M 10-Q · filed 2016-08-09 | -$7.04M derived: sum of 3 quarters · filed 2017-08-21 | -$9.04M derived: sum of 4 quarters · filed 2017-08-21 |
| 2016-03-31 | -$2.68M 10-Q · filed 2017-05-15 | -$5.42M derived: sum of 2 quarters · filed 2017-05-15 | -$7.42M derived: sum of 3 quarters · filed 2017-05-15 | ||
| 2015-12-31 | -$2.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17 | -$4.74M derived: sum of 2 quarters · filed 2017-04-17 | -$6.75M 10-K · filed 2017-04-17 | ||
| 2015-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$4.01M 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | -$2.02M 10-Q · filed 2016-08-09 |